Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 14:23:07 UTC |
---|
Update Date | 2021-09-26 23:09:19 UTC |
---|
HMDB ID | HMDB0254904 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Motolimod |
---|
Description | Motolimod belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). Motolimod is a very strong basic compound (based on its pKa). In June 2018, the combination of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) was approved by the Food and Drug Administration for the treatment of people with unresectable or metastatic BRAF V600E or V600K mutation-positive melanoma. In 2017, the company spun out one of its programs into a subsidiary called Yarra; the asset was a molecule called ARRY-797 that was in a Phase II trial for cardiomyopathy. In May 2017, the company partnered with Ono Pharmaceutical to test the combination of binimetinib and encorafenib while retaining commercialization rights in the U.S. and other markets. In July 2019, Pfizer acquired the company. In November 2015, the company signed a partnership with Laboratoires Pierre Fabre. The company focuses on oncology medication. Array BioPharma is a U.S.-based, clinical stage, pharmaceutical company. In July 2013, the company partnered with Loxo Oncology to develop cancer drugs. This compound has been identified in human blood as reported by (PMID: 31557052 ). Motolimod is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Motolimod is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC1 InChI=1S/C28H34N4O2/c1-3-13-31(14-4-2)28(34)24-17-23-12-11-22(18-25(23)30-26(29)19-24)20-7-9-21(10-8-20)27(33)32-15-5-6-16-32/h7-12,17-18H,3-6,13-16,19H2,1-2H3,(H2,29,30) |
---|
Synonyms | Value | Source |
---|
VTX-378VTX-2337MOTOLIMOD | ChEMBL |
|
---|
Chemical Formula | C28H34N4O2 |
---|
Average Molecular Weight | 458.606 |
---|
Monoisotopic Molecular Weight | 458.268176351 |
---|
IUPAC Name | 2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide |
---|
Traditional Name | 2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCN(CCC)C(=O)C1=CC2=CC=C(C=C2N=C(N)C1)C1=CC=C(C=C1)C(=O)N1CCCC1 |
---|
InChI Identifier | InChI=1S/C28H34N4O2/c1-3-13-31(14-4-2)28(34)24-17-23-12-11-22(18-25(23)30-26(29)19-24)20-7-9-21(10-8-20)27(33)32-15-5-6-16-32/h7-12,17-18H,3-6,13-16,19H2,1-2H3,(H2,29,30) |
---|
InChI Key | QSPOQCXMGPDIHI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzazepines |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzazepines |
---|
Alternative Parents | |
---|
Substituents | - Benzazepine
- Benzamide
- Benzoic acid or derivatives
- Benzoyl
- N-acylpyrrolidine
- Azepine
- Monocyclic benzene moiety
- Imidolactam
- Benzenoid
- Tertiary carboxylic acid amide
- Pyrrolidine
- Carboxamide group
- Amidine
- Azacycle
- Carboxylic acid amidine
- Organic 1,3-dipolar compound
- Carboxylic acid derivative
- Propargyl-type 1,3-dipolar organic compound
- Carbonyl group
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Motolimod,1TMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C)C1 | 4295.4 | Semi standard non polar | 33892256 | Motolimod,1TMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C)C1 | 3865.8 | Standard non polar | 33892256 | Motolimod,1TMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C)C1 | 5902.2 | Standard polar | 33892256 | Motolimod,2TMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C)[Si](C)(C)C)C1 | 4334.1 | Semi standard non polar | 33892256 | Motolimod,2TMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C)[Si](C)(C)C)C1 | 3985.6 | Standard non polar | 33892256 | Motolimod,2TMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C)[Si](C)(C)C)C1 | 5647.5 | Standard polar | 33892256 | Motolimod,1TBDMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C(C)(C)C)C1 | 4518.7 | Semi standard non polar | 33892256 | Motolimod,1TBDMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C(C)(C)C)C1 | 4073.3 | Standard non polar | 33892256 | Motolimod,1TBDMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N[Si](C)(C)C(C)(C)C)C1 | 5853.6 | Standard polar | 33892256 | Motolimod,2TBDMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1 | 4689.7 | Semi standard non polar | 33892256 | Motolimod,2TBDMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1 | 4384.3 | Standard non polar | 33892256 | Motolimod,2TBDMS,isomer #1 | CCCN(CCC)C(=O)C1=CC2=CC=C(C3=CC=C(C(=O)N4CCCC4)C=C3)C=C2N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1 | 5581.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Motolimod GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4r-3009300000-61d176283c6bb192a7bd | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Motolimod GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 10V, Positive-QTOF | splash10-0a4i-2103900000-96e519c0f62aa7e1d6af | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 20V, Positive-QTOF | splash10-0536-4119400000-185e29e9ad83af1e38e9 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 40V, Positive-QTOF | splash10-0006-9060000000-38b8ce6b0bf61ff65a1b | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 10V, Negative-QTOF | splash10-0a4i-0000900000-115bd3957f84fd7a694a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 20V, Negative-QTOF | splash10-0a4j-5403900000-ab185407c25bf177ee1e | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 40V, Negative-QTOF | splash10-0006-9001000000-1f12a104754b39bd0868 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 10V, Positive-QTOF | splash10-0a4i-0001900000-42b59379cf8899f1475d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 20V, Positive-QTOF | splash10-0a4i-8009700000-5c4cf7cbaf88fa75d85c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 40V, Positive-QTOF | splash10-0006-9015400000-7883eddcffe3c39ceade | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 10V, Negative-QTOF | splash10-0a4i-0000900000-3730f7726aac8ae4ca8e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 20V, Negative-QTOF | splash10-0a4i-1103900000-921d0b065b69f91e1f8a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Motolimod 40V, Negative-QTOF | splash10-053r-4019300000-295124a047502e5cd1e6 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|